34 C
Agartala
Monday, June 24, 2024

Elon Musk’s Neuralink gets FDA approval for in-human clinical study

Date:

 Neuralink, Elon Musk’s brain-machine interface company, announced that it has received approval from the U.S. Food and Drug Administration (FDA) to conduct its first in-human clinical study.

“This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people,” the company tweeted.

Neuralink said recruitment for its clinical trial “is not open yet.”

The FDA has not commented on the trial. And the extent of the approved trial is not known yet.

Neuralink was founded in 2016 and funded primarily by Musk to develop a new kind of interface technology between the human brain and computing devices.

Installing a chip in the human skull could restore limb function, improve human movement, resolve issues with eyesight and hearing, and help with diseases like Parkinson’s, the company claims.

Share post:

Subscribe

Adspot_imgspot_img

Popular

More like this
Related

Tripura Police Recover Three Bodies in Separate Incidents

BY TC News Desk Agartala, 23rd June 2024:  As many...

Over 20 Hospitalized with Suspected Food Poisoning in Kalyanpur

By TC News Desk Agartala, 23rd June 2024 : Thirty...

CM Sends 500 Kgs of Queen Pineapple to Bangladesh PM Hasina

By TC News Desk Agartala, 23rd June 2024 : In...

IPFT’s preparatory meeting for village committee polls

BY TC News Desk Agartala, 22nd June 2024:  The ruling...